Literature DB >> 2766898

Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium.

M W Mulholland1, B J Reid, D S Levine, C E Rubin.   

Abstract

Gastric acid secretion in response to a protein meal and to exogenously administered synthetic human gastrin 17-I was measured in patients with Barrett's esophagus, patients with uncomplicated gastroesophageal reflux, and normal age- and sex-matched controls. Acid secretion, both basally and in response to gastrin 17-I, was significantly greater in patients with Barrett's esophagus compared to normal individuals without reflux. Basal gastrin levels and meal-stimulated levels of the hormone were similar among all three groups. Sensitivity to gastrin, expressed as the concentration causing half-maximal acid secretion, was also similar among the study groups. It is speculated that elevated basal acid production in Barrett's esophagus may contribute to the pathogenesis of the disorder.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766898     DOI: 10.1007/BF01538064

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  Barrett-esophagus following total gastrectomy. A contribution to it's pathogenesis.

Authors:  W Meyer; F Vollmar; W Bär
Journal:  Endoscopy       Date:  1979-05       Impact factor: 10.093

2.  Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux.

Authors:  L F Johnson; T R Demeester
Journal:  Am J Gastroenterol       Date:  1974-10       Impact factor: 10.864

3.  New clinical method for measuring the rate of gastric emptying: the double sampling test meal.

Authors:  J D George
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

Review 4.  Barrett's esophagus.

Authors:  S J Spechler; R K Goyal
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

5.  Effect of long-term treatment with cimetidine and antacids in Barrett's oesophagus.

Authors:  I C Wesdorp; J Bartelsman; M E Schipper; G N Tytgat
Journal:  Gut       Date:  1981-09       Impact factor: 23.059

6.  Adenocarcinoma and Barrett's esophagus. An overrated risk?

Authors:  S J Spechler; A H Robbins; H B Rubins; M E Vincent; T Heeren; W G Doos; T Colton; E M Schimmel
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

7.  Glucose perfusion intragastric titration.

Authors:  V Maxwell; V E Eysselein; J Kleibeuker; T Reedy; J H Walsh
Journal:  Dig Dis Sci       Date:  1984-04       Impact factor: 3.199

8.  Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.

Authors:  B J Reid; R C Haggitt; C E Rubin; P S Rabinovitch
Journal:  Gastroenterology       Date:  1987-07       Impact factor: 22.682

9.  Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas.

Authors:  A P Naef; M Savary; L Ozzello
Journal:  J Thorac Cardiovasc Surg       Date:  1975-11       Impact factor: 5.209

10.  Progression of cimetidine-treated reflux esophagitis to a Barrett's stricture.

Authors:  M Saltzman; K Barwick; R W McCallum
Journal:  Dig Dis Sci       Date:  1982-02       Impact factor: 3.199

View more
  10 in total

1.  Pathogenetic factors affecting gastroesophageal reflux in patients with esophagitis and concomitant duodenal ulcer: a multivariate analysis.

Authors:  Hui-Ming Zhu; Xun Huang; Chuang-Zheng Deng; G Pianchi Porro; F Pace; O Sangaletti
Journal:  World J Gastroenterol       Date:  1998-04       Impact factor: 5.742

2.  Pyloroplasty and the risk of Barrett's esophagus in patients with gastroparesis.

Authors:  Motasem Alkhayyat; Vedha Sanghi; Thabet Qapaja; Robert Butler; Carol Rouphael; John McMichael; John Goldblum; Madhusudhan R Sanaka; Prashanthi N Thota
Journal:  Dis Esophagus       Date:  2020-11-18       Impact factor: 3.429

Review 3.  How to make a Barrett esophagus: pathophysiology of columnar metaplasia of the esophagus.

Authors:  Philippe G Guillem
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

4.  Low circulating levels of gastrin-17 in patients with Barrett's esophagus.

Authors:  Pentti Sipponen; Matti Vauhkonen; Timo Helske; Ilpo Kaariainen; Matti Harkonen
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

5.  Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus.

Authors:  M J Collen; D A Johnson
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

6.  Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.

Authors:  R H Holloway; J Dent; F Narielvala; A M Mackinnon
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

Review 7.  Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management.

Authors:  H J Stein; J R Siewert
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

8.  Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease. Correlation with ranitidine therapy.

Authors:  M J Collen; D A Johnson; M J Sheridan
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

9.  Time pattern of gastric acidity in Barrett's esophagus.

Authors:  V Savarino; G S Mela; P Zentilin; M R Mele; C Mansi; A C Remagnino; S Vigneri; A Malesci; M Belicchi; G Lapertosa; G Celle
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

10.  Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls.

Authors:  B I Hirschowitz
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.